MRI Kardiak untuk Gagal Jantung akibat Kardiomiopati
Abstract
Kardiomiopati (KM) merupakan penyakit miokardium dengan karakteristik gangguan yang nyata pada morfologi, elektrofisiologi dan fungsi jantung.1 Definisilain menyebutkan bahwa KM adalah kelainan miokardium dengan abnormalitas pada struktur dan fungsi otot jantung, tanpa adanya penyakit jantung koroner, hipertensi, penyakit jantung katup ataupun kongenital yang melatarbelakanginya.
Kardiomiopati dapat diklasifikasikan dalam dua kelompok besar yaitu KM primer dan KM sekunder. KM primer merupakankardiomiopati yang etiologinya
tidak diketahui sedangkan kardiomiopati sekunder merupakan kardiomiopati yang diketahui etiologinya atau terkait kelainan sistemik maupun kelainan
miokardium khusus lainnya.2 Penegakan diagnosis KM dan klasifikasinya
didasarkan pada penilaian morfologi dan fungsi jantung.3 Penetapan diagnosis KM primer dilakukan dengan mengeksklusi penyakit/kelainan jantung yang
lain.4 Seiring pengamatan klinis, perbedaan antara KM primer dan sekunder akan menjadi semakin jelas, karena ditemukannya etiologi pada kasus
yang sebelumnya dianggap merupakan kelainan idiopatik.2
Downloads
Download data is not yet available.
References
Jagia P, Gulati G, Sharma S. Cardiac Magnetic Resonance in
the Assessment of Cardiomyopathies. Indian J Radiol Imaging.
2007;17:109-19.
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F.
Classi?cation of the Cardiomyopathies: a Position Statement
From the European Society of Cardiology Working Group on
Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270-6.
Quarta G, Sado D, Moon J. Cardiomyopathies: Focus on
Cardiovascular Magnetic Resonance. The British Journal of
Radiology. 2011;84:296-305.
O’Hanlon R, Pennell D, Schulz-Menger J, Wabmuth R. Differentiation of Cardiomyopathies by use of CMR. Magnetom
Flash. 2007;2:22-33.
McCartan C, Mason R, Jayasinghe S, Griffiths L. Cardiomyopathy Classi?cation: Ongoing Debate in the Genomics Era.Biochemistry Research International. 2012:1-10.
Mahrholdt H, Wagner A, Judd R, Sechtem U, Kim R. Delayed
enhancement cardiovascular magnetic resonance assessment of
non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461-
74.
Park J, Kwon D, Starling R, Marwick T. Role of Imaging in
the Detection of Reversible Cardiomyopathy. J Cardiovasc
Ultrasound. 2013;21(2):45-55.
m
mcMurray J, Adamopoulos S, Anker S, Auricchio A, Bohm M.
ESC Guidelines for the diagnosis and treatment of acute and
chronic heart failure 2012. Eur Heart J. 2012;33:1787-847.
Kramer C, Barkhausen J, Flamm S, Kim R, Nagel E. Standardized
Cardiovascular Magnetic Resonance Imaging (CMR)
protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. Journal of Cardiovascular Magnetic Resonance. 2008 10:35.
Gersh B, Phil D, Maron B, Bonow R, Dearani J. ACCF/AHA
Guideline for the Diagnosis and Treatment of Hypertrophic
Cardiomyopathy. JACC. 2011;58:213-60.
Rickers C, Wilke N, Jerosch-Herlod M, Casey S, Panse P. Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy. Circulation. 2005;112:855- 61.
Valente A, Lakdawala N, Powell A, Evans S, Cirino A. Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers Without Left Ventricular Hypertrophy. Circulation
Cardiovascular Genetics. 2013;6:230-7.
13. Ahmad F, Li D, Karibe A, Gonzalez O, Tapscott T, Hill R, et
al. Localization of a Gene Responsible for Arrhythmogenic
Right Ventricular Dysplasia to Chromosome 3p23. Circulation.
1998;98:2791-5.
the Assessment of Cardiomyopathies. Indian J Radiol Imaging.
2007;17:109-19.
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F.
Classi?cation of the Cardiomyopathies: a Position Statement
From the European Society of Cardiology Working Group on
Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270-6.
Quarta G, Sado D, Moon J. Cardiomyopathies: Focus on
Cardiovascular Magnetic Resonance. The British Journal of
Radiology. 2011;84:296-305.
O’Hanlon R, Pennell D, Schulz-Menger J, Wabmuth R. Differentiation of Cardiomyopathies by use of CMR. Magnetom
Flash. 2007;2:22-33.
McCartan C, Mason R, Jayasinghe S, Griffiths L. Cardiomyopathy Classi?cation: Ongoing Debate in the Genomics Era.Biochemistry Research International. 2012:1-10.
Mahrholdt H, Wagner A, Judd R, Sechtem U, Kim R. Delayed
enhancement cardiovascular magnetic resonance assessment of
non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461-
74.
Park J, Kwon D, Starling R, Marwick T. Role of Imaging in
the Detection of Reversible Cardiomyopathy. J Cardiovasc
Ultrasound. 2013;21(2):45-55.
m
mcMurray J, Adamopoulos S, Anker S, Auricchio A, Bohm M.
ESC Guidelines for the diagnosis and treatment of acute and
chronic heart failure 2012. Eur Heart J. 2012;33:1787-847.
Kramer C, Barkhausen J, Flamm S, Kim R, Nagel E. Standardized
Cardiovascular Magnetic Resonance Imaging (CMR)
protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. Journal of Cardiovascular Magnetic Resonance. 2008 10:35.
Gersh B, Phil D, Maron B, Bonow R, Dearani J. ACCF/AHA
Guideline for the Diagnosis and Treatment of Hypertrophic
Cardiomyopathy. JACC. 2011;58:213-60.
Rickers C, Wilke N, Jerosch-Herlod M, Casey S, Panse P. Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy. Circulation. 2005;112:855- 61.
Valente A, Lakdawala N, Powell A, Evans S, Cirino A. Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers Without Left Ventricular Hypertrophy. Circulation
Cardiovascular Genetics. 2013;6:230-7.
13. Ahmad F, Li D, Karibe A, Gonzalez O, Tapscott T, Hill R, et
al. Localization of a Gene Responsible for Arrhythmogenic
Right Ventricular Dysplasia to Chromosome 3p23. Circulation.
1998;98:2791-5.
Published
2015-04-01
Views & Downloads
Abstract views: 3564
PDF downloads: 4050
PDF downloads: 4050
How to Cite
Wicaksono, S., Syamsul, D., Primasari, C., Gayatri, A., & Permana, A. (2015). MRI Kardiak untuk Gagal Jantung akibat Kardiomiopati. Indonesian Journal of Cardiology, 34(4), 280-8. https://doi.org/10.30701/ijc.v34i4.387
Section
Forum Pencitraan
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
